Access our support and expertise:
Familial hypercholesterolaemia (FH) is a common inherited condition, yet it often goes undiagnosed, leaving patients at significantly increased risk of premature cardiovascular disease. Early identification is key - and that’s where FAMCAT2 comes in.
Developed and deployed by colleagues at the University of Nottingham, FAMCAT2 is a validated clinical algorithm that uses routinely collected primary care data to identify individuals at increased risk of FH. By ranking patients based on their likelihood of having the condition, FAMCAT2 improves the precision of FH risk identification, helping to:
This free webinar will be led by experts from the University of Nottingham, including PRIMIS, who were directly involved in the development, validation, and deployment of the algorithm, alongside practitioners who have successfully implemented FAMCAT2 within their localities.
What you’ll learn:
Who should attend:
This session is ideal for GPs, practice nurses, pharmacists, PCN leads, cardiovascular risk specialists, and anyone involved in improving the detection and management of FH.
Join us to gain practical insights into using FAMCAT2 to transform FH detection and improve patient outcomes.
Find out more and register to attend here.